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A B S T R A C T
The aim of this paper is to compare diameter of healthy and affected optic nerve determined by ultrasound with
brain lesions in acute retrobulbar neuritis in patients with multiple sclerosis. In this prospective study 20 patients with
multiple sclerosis and acute retrobulbar neuritis were examined. Optic nerve diameter was measured by ultrasound.
Brain lesions were detected by magnetic resonance. Correlation between demyelinating lesions of the brain in multiple
sclerosis and optic nerve diameter was tested by Kruskal-Wallis test. Significant difference in diameter between he-
althy and affected optic nerve in acute retrobulbar neuritis was found. Demyelinating brain changes examined by
magnetic resonance revealed periventricular lesions, subcortical lesions and lesions in corpus callosum. There is statis-
tically significant correlation between optic nerve diameter and number of brain lesions in multiple sclerosis, p<0.05. Di-
ameter of optic nerve in retrobulbar neuritis measured by ultrasound correlates with brain lesions detected by mag-
netic resonance in multiple sclerosis.
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Introduction
Multiple sclerosis (MS) is remittent chronic disease
characterized by demyelinating plaques, spread through
cerebral white matter lesions1. MS is one of the most
frequent neurological disorders2 with different etiologi-
cal factors: genetic, immunological, environmental, in-
fectious, stress factors and others. Many others neuro-
logical diseases can mimic clinical features of MS. Most
patients who develop clinically definite MS following an
initial episode of optic neuritis will have a relatively be-
nign course for at least 10 years. Retrobulbar neuritis
(RN) has incidence of 62% in MS3.
There is no specific laboratory test for MS diagnosis.
Clinical characteristics, magnetic resonance imaging
(MRI) pattern of abnormalities, evoked potential stud-
ies and cerebrospinal fluid oligoclonal band analysis are
of high diagnostic yield in late onset MS patients, but
expertise in interpreting their results is strongly re-
quired1.
McDonald’s criteria for MS were established based
on different diagnostic procedures4.
MRI is most indicative method for evaluation and
clinical follow-up of MS. In case that MRI detects demy-
elinating lesions of cerebral white matter 5-year-risk for
MS development is 60% and if there is no MRI confirma-
tion risk is only 5%5.
Four-parameter dichotomized MRI model including
gadolinium-enhancement, juxtacortical, infratentorial
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and periventricular lesions best predicts conversion to
clinically definite multiple sclerosis. Lesions detected by
MRI can be classified according to size and number ad-
ditionally to localization. Frederiksen quantification
based on size and number of the lesions revealed by
MRI is most accepted classification6.
MRI is, however, valuable for differential diagnosis
of RN in MS and RN caused by optic nerve tumor; nico-
tine-alcohol based visual loss and benign intracranial
hypertension7.
RN diagnosis is achieved by anamnesis, extensive
ophthalmologic examination, laboratory tests, MRI and
visual evoked potentials.
Ultrasound examination of the optic nerve can be
performed with A-scan and B-scan method. A-scan me-
thod is most sensitive method for detection of the optic
nerve damage, and is precise for measurement of optic
nerve thickness. Normal thickness of the optic nerve is
2.4–3.4 mm and diameter difference larger than 0.3 mm
in two eyes of the same person is considered patho-
logical8.
There is still unknown mechanism how demyeli-
nating plaques influence optic nerve diameter changes
in patients with acute RN in MS.
Purpose of this prospective study was to investigate
correlation between optic nerve diameter changes mea-
sured by ultrasound A-scan method with the cerebral
white matter demyelinating lesions detected by MRI in
patients with MS who had first attack of RN.
Patients and Methods
In this research 20 patients 17 to 35 years old with
average age of 25.7 were studied. There were 7 male
(35%) and 13 female (65%). All of them fulfilled McDon-
ald’s criteria for MS and they had first attack of RN. RN
was confirmed by clinical course: pain during eye move-
ment, visual acuity decrease, narrowing of visual field,
and color vision disturbances.
Optic nerve diameter was determined by ultrasound
A-scan method. Nidec Echo-Scan US 3000 Ltd was used
with 10 MHz tube, canton, MA, USA, 1995. Measure-
ments were performed during the first two or three days
after initial symptoms because after that time usually
corticosteroid regimen is applied and it can interfere
with results.
MRI detected lesions of the white brain matter. Gen-
eral Electric Max Plus 0.5 T New York, USA, 1995 and
Hitachi 0.2 T, Twinsburg, Ohio, USA, 1989, were used.
Lesions were divided according to localization in peri-
ventricular lesions, subcortical lesions, lesions of corpus
callosum and others. Lesions were classified by Freder-
ick‘s classification.
Statistical analysis
Qualitative data was analyzed with frequency ta-
bles. Quantitative data was described by arithmetic
midpoint, standard deviation and centile distribution.
Correlation between qualitative data is shown with
contingency tables. Correlation between quantitative
variables was analyzed by Kruskall-Wallis test. The
level of significance was set at p<0.05.
Results
Ultrasound examination showed that optic nerve di-
ameter of the eye with RN is 0.6 mm larger than optic
nerve diameter of the healthy eye (Table 1).
Demyelinating lesions of the brain detected by MRI
according to localization revealed that all patients had
periventricular lesions. Subcortical lesions had 70% of
examined patients while 10% had lesions in corpus cal-
losum.
Number and size of the lesions were ordered by
Frederiksen quantification (Table 2).
Majority of the patients had 2–15 lesions with size
equal or less than 15 mm. There was no significant cor-
relation between Frederiksen quantification in gender,
painfulness in eye during rest and eye movement.
Connection between brain lesions and visual acuity
in patients with RN was obtained by Kruskall-Wallis
test and it revealed statistically significant correlation
with p<0.05 (Table 3).
Optic nerve diameter measured by ultrasound in cor-
relation with brain lesions detected by MRI showed sta-
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TABLE 1
ARITHMETIC MIDPOINT OF OPTIC NERVE DIAMETER
COMPARED WITH RETROBULBAR NEURITIS AND ARITHMETIC





SD Min Max Median
Healthy nerve 3.6 0.6 2.9 4.7 3.5
Affected nerve 4.2 0.7 3.0 5.4 4.2
Difference 0.6 0.4 0.1 1.5 0.6
Min – minimum, Max – maximum
TABLE 2
FREDERIKSEN QUANTIFICATION OF DEMYELINATING LE-
SIONS DETECTED BY MRI IN PATIENTS WITH RETROBULBAR










1. 2–6  6 4 (20%)
2. 7–15  6 2 (10%)
3. 2–15  15 6 (30%)
4. 16–25  15 2 (10%)
5. 26  15 4 (20%)
6. 1 > 15 2 (10%)
tistically significant result with p<0.05 both when he-
althy eye and eye affected by RN optic nerve diameter
was measured and compared with MRI distinguished
brain lesions.
Discussion
Retrobulbar neuritis is present in 40% of all patients
with MS9. It is very important for MS diagnosis, clinical
follow-up and prognosis to acquire as more information
as we can to achieve better outcome. According to rele-
vant literature diameter of the optic nerve with RN en-
largement in comparison with healthy optic nerve is sig-
nificant if difference is more than 0.3 mm10.
Results presented in this research showed signifi-
cant difference of 0.6 mm.
MRI especially during or following a first attack, can
be helpful in providing evidence of lesions in other parts
of the brain and spinal cord. MRI has significantly ex-
tended the understanding of MS, owing to its ability to
sensitively depict the dynamics of the disease process in
vivo1,7. Demyelinating lesions obtained with MRI are
usually found in periventricular region, subcortical re-
gion and in corpus callosum11,12, and results of this
study confirmed these findings.
There was no data previously reported in the litera-
ture any data about correlation between diameter dif-
ference of the optic nerve measured by ultrasound and
MRI detected brain lesions in MS patients with acute
attack of RN.
In this research was found statistically significant
correlation between optic nerve diameter in RN mea-
sured by ultrasound and number of lesions detected by
MRI analyzed by Kruskal-Wallis test. There was also
significant correlation between healthy optic nerve di-
ameter measured by ultrasound and brain lesions de-
tected by MRI.
In conclusion, ultrasound measurement of the optic
nerve is very valuable and straightforward method for
RN diagnosis in MS because enlargement of the optic
nerve diameter correlates significantly with MRI ob-
tained lesions in patients with MS.
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TABLE 3
VISUAL ACTIVITY AND FREDERIKSEN QUANTIFICATION
Frederiksen quantification










y 0.01–0.09 0 (0%) 2 (10%) 0 (0%) 0 (0%) 0 (0%) 2 (10%)
0.1–0.3 0 (0%) 0 (0%) 4 (20%) 2 (10%) 0 (0%) 0 (0%)
0.6–0.8 2 (10%) 0 (0%) 2 (10%) 0 (0%) 2 (10%) 0 (0%)
light perception 2 (10%) 0 (0%) 0 (0%) 0 (0%) 2 (10%) 0 (0%)
p<0.05
KORELACIJA PROMJERA VIDNOG @IVCA U AKUTNOM RETROBULBARNOM NEURITISU
I MO@DANIH PROMJENA KOD MULTIPLE SKLEROZE
S A @ E T A K
Cilj ovog rada je usporediti promjere zdravog i bolesnog vidnog `ivca mjerene ultrazvukom sa mo`danim lezijama
u akutnom retrobulbarnom neuritisu kod multiple skleroze. Ispitivano je 20 bolesnika koji boluju od multiple skle-
roze i imali su retrobulbarni neuritis. Promjer vidnog `ivca je mjeren ultrazvukom. Mo`dane lezije su otkrivene sa
magnetskom rezonancom. Korelacija izme|u demijeliniziraju}ih lezija mozga u multiploj sklerozi i promjera vidnog
`ivca je testirana sa Kruskal-Wallisovim testom. Na|ena je zna~ajna razlika izme|u promjera zdravog i bolesnog
opti~kog `ivca u retrobulbarnom neuritisu. Demijeliniziraju}e promjene mozga ispitivane magnetskom rezonancom
detektirane su u periventrikularnom i subkortikalnom podru~ju, te u korpusu kalozumu. Na|ena je statisti~ki zna-
~ajna korelacija izme|u promjera vidnog `ivca i broja mo`danih lezija kod multiple skleroze, p<0.05. Promjer vidnog
`ivca u retrobulbarnom neuritisu mjeren sa ultrazvukom korelira sa lezijama mozga detektiranim sa magnetskom
rezonancom kod multiple skleroze.
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